 |
 |
 |
 |
VA Dental Diabetes Study: Twelve month results
J.A. JONES1, D. MILLER1, C. WEHLER1, S. RICH1, E. KAYE1, L. MCCOY1, C. CHRISTIANSEN1, J. ROTHENDLER1, A. EMAM2, and R. GARCIA1, 1Boston University and Department of Veterans Affairs, MA, USA, 2Boston University, MA, USA | Objective: The relationship between periodontitis and diabetes is complex and persons with diabetes are more likely to have periodontal disease. A related question is whether periodontal therapy improves glycemic control among persons with poorly controlled diabetes. Here we report results of four-months versus twelve-months of structured periodontal treatment in a randomized clinical trial of the efficacy of periodontal care in the improvement of glycemic control in veterans with poorly controlled diabetes. Methods: We enrolled 162 veterans (mean age=59, mean number of teeth = 21) with poorly controlled diabetes defined as HbA1c >8.5% on at least 2 occasions. They were randomly assigned to four months or twelve months of therapy, including initial scaling and root planing plus doxycycline 100 mgm po * 14days and 0.12% chlorhexidine rinse * 4 months. Antimicrobials were not continued after the first 4 months in either group. Outcomes included the percent of participants with improvement in hemoglobin A1c (HbA1c) between pretreatment and 1-year post-treatment initiation in the FOUR MONTHS versus TWELVE MONTHS therapy groups. Analyses included simple/multiple variable logistic regressions, adjusted for baseline HbA1c, age over 55 years, and increasing insulin over the 12-month period. Results: Unadjusted analyses of change after 12 months showed that the percent with HbA1c improvement was greater in the FOUR MONTHS OF THERAPY GROUP (52%) versus the TWELVE MONTHS OF THERAPY GROUP (35%), p=0.03. Odds of improvement in the TWELVE MONTH group were 0.36 (95%CI: 0.16,0.78) relative to the FOUR MONTH group, after adjusting for age>55, baseline HbA1c, and increases in insulin. Conclusions: Veterans with poorly controlled diabetes who had periodontal therapy for only 4 months had a greater likelihood of improvement in HbA1c at 12 months after initiation of therapy compared to those treated for 12 months. VA HSR&D QUERI DII-99.206 and NIH K24 DE00419 and NIH K24 DE018211 |
Seq #86 - Geriatric Oral Research 8:00 AM-9:30 AM, Friday, April 4, 2008 Hilton Anatole Hotel Sapphire |
Back to the Geriatric Oral Research Program
|
|